C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo

被引:27
|
作者
Ruseva, M. M. [1 ]
Takahashi, M. [2 ]
Fujita, T. [2 ]
Pickering, M. C. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, London W12 0NN, England
[2] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Japan
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2014年 / 176卷 / 01期
基金
日本学术振兴会; 英国惠康基金;
关键词
MASP-1/3; complement; kidney; ALTERNATIVE COMPLEMENT PATHWAY; HUMAN SERUM; NOR MASP-3; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; FACTOR-B; ACTIVATION; GLOMERULOPATHY; MUTATIONS; MECHANISM; ZYMOGEN;
D O I
10.1111/cei.12244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Uncontrolled activation of the complement alternative pathway is associated with complement-mediated renal disease. Factor B and factor D are essential components of this pathway, while factor H (FH) is its major regulator. In complete FH deficiency, uncontrolled C3 activation through the alternative pathway results in plasma C3 depletion and complement-mediated renal disease. These are dependent on factor B. Mannan-binding lectin-associated serine proteases 1 and 3 (MASP-1, MASP-3) have been shown recently to contribute to alternative pathway activation by cleaving pro-factor D to its active form, factor D. We studied the contribution of MASP-1 and MASP-3 to uncontrolled alternative pathway activation in experimental complete FH deficiency. Co-deficiency of FH and MASP-1/MASP-3 did not ameliorate either the plasma C3 activation or glomerular C3 accumulation in FH-deficient mice. Our data indicate that MASP-1 and MASP-3 are not essential for alternative pathway activation in complete FH deficiency.
引用
收藏
页码:84 / 92
页数:9
相关论文
共 50 条
  • [31] Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and-2 Provides Insight on Lectin Pathway Activation
    Nan, Ruodan
    Furze, Christopher M.
    Wright, David W.
    Gor, Jayesh
    Wallis, Russell
    Perkins, Stephen J.
    STRUCTURE, 2017, 25 (02) : 364 - 375
  • [32] Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules
    Rossi, V
    Teillet, F
    Thielens, NM
    Bally, I
    Arlaud, GJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (51) : 41811 - 41818
  • [33] Quantitative Characterization of the Activation Steps of Mannan-binding Lectin (MBL)-associated Serine Proteases (MASPs) Points to the Central Role of MASP-1 in the Initiation of the Complement Lectin Pathway
    Megyeri, Marton
    Harmat, Veronika
    Major, Balazs
    Vegh, Adam
    Balczer, Julia
    Heja, David
    Szilagyi, Katalin
    Datz, Daniel
    Pal, Gabor
    Zavodszky, Peter
    Gal, Peter
    Dobo, Jozsef
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (13) : 8922 - 8934
  • [34] Plasma levels of mannan-binding lectin-associated serine proteases are increased in type 1 diabetes patients with insulin resistance
    Kietsiriroje, Noppadol
    Scott, Georgia E.
    Ajjan, Ramzi A.
    Broz, Jan
    Schroeder, Verena
    Campbell, Matthew D.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, : 58 - 64
  • [35] Targeted inhibition by RNA interference-mediated gene silencing of mannan-binding lectin-associated serine protease (MASP)-1/3 expression attenuates collagen antibody-induced arthritis (CAIA)
    Banda, Nirmal K.
    Acharya, Sumitra
    Scheinman, Robert I.
    Mehta, Gaurav
    Takahashi, Minoru
    Mortensen, Simon
    Thiel, Steffen
    Sekine, Hideharu
    Fujita, Teizo
    Holers, V. Michael
    IMMUNOBIOLOGY, 2016, 221 (10) : 1131 - 1132
  • [36] Essential role of mannose-binding lectin-associated serine proteases-1/3 (MASP-1/3) in the development of lupus-like gromerulonephritis in MRL/lpr mice
    Sakamoto, Natsumi
    Machida, Takeshi
    Takahashi, Minoru
    Fujita, Teizo
    Sekine, Hideharu
    IMMUNOBIOLOGY, 2016, 221 (10) : 1166 - 1166
  • [37] The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2–3
    C Stover
    Y Endo
    M Takahashi
    NJ Lynch
    C Constantinescu
    T Vorup-Jensen
    S Thiel
    H Friedl
    T Hankeln
    R Hall
    S Gregory
    T Fujita
    W Schwaeble
    Genes & Immunity, 2001, 2 : 119 - 127
  • [38] The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3
    Stover, C
    Endo, Y
    Takahashi, M
    Lynch, NJ
    Constantinescu, C
    Vorup-Jensen, T
    Thiel, S
    Friedl, H
    Hankeln, T
    Hall, R
    Gregory, S
    Fujita, T
    Schwaeble, W
    GENES AND IMMUNITY, 2001, 2 (03) : 119 - 127
  • [39] Mannan-binding lectin-associated serine protease 3 cleaves synthetic peptides and insulin-like growth factor-binding protein 5
    Cortesio, Christa L.
    Jiang, Weiping
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2006, 449 (1-2) : 164 - 170
  • [40] Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2
    Yaseen, Sadam
    Demopulos, Gregory
    Dudler, Thomas
    Yabuki, Munehisa
    Wood, Christi L.
    Cummings, W. Jason
    Tjoelker, Larry W.
    Fujita, Teizo
    Sacks, Steven
    Garred, Peter
    Andrew, Peter
    Sim, Robert B.
    Lachmann, Peter J.
    Wallis, Russell
    Lynch, Nicholas
    Schwaeble, Wilhelm J.
    FASEB JOURNAL, 2017, 31 (05): : 2210 - 2219